JP2021524481A5 - - Google Patents
Info
- Publication number
- JP2021524481A5 JP2021524481A5 JP2021500215A JP2021500215A JP2021524481A5 JP 2021524481 A5 JP2021524481 A5 JP 2021524481A5 JP 2021500215 A JP2021500215 A JP 2021500215A JP 2021500215 A JP2021500215 A JP 2021500215A JP 2021524481 A5 JP2021524481 A5 JP 2021524481A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- groups
- alkyl
- substituted
- cycloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023179000A JP7673362B2 (ja) | 2018-07-09 | 2023-10-17 | Ｒｎａウィルス感染を処置する為のフェニル－ｎ－キノリン誘導体 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18305910.4 | 2018-07-09 | ||
| EP18305910.4A EP3594206A1 (en) | 2018-07-09 | 2018-07-09 | Phenyl-n-quinoline derivatives for treating a rna virus infection |
| PCT/EP2019/068459 WO2020011810A1 (en) | 2018-07-09 | 2019-07-09 | Phenyl-n-quinoline derivatives for treating a rna virus infection |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023179000A Division JP7673362B2 (ja) | 2018-07-09 | 2023-10-17 | Ｒｎａウィルス感染を処置する為のフェニル－ｎ－キノリン誘導体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021524481A JP2021524481A (ja) | 2021-09-13 |
| JP2021524481A5 true JP2021524481A5 (enExample) | 2022-06-23 |
| JP7504409B2 JP7504409B2 (ja) | 2024-06-24 |
Family
ID=63035966
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021500215A Active JP7504409B2 (ja) | 2018-07-09 | 2019-07-09 | Ｒｎａウィルス感染を処置する為のフェニル－ｎ－キノリン誘導体 |
| JP2023179000A Active JP7673362B2 (ja) | 2018-07-09 | 2023-10-17 | Ｒｎａウィルス感染を処置する為のフェニル－ｎ－キノリン誘導体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023179000A Active JP7673362B2 (ja) | 2018-07-09 | 2023-10-17 | Ｒｎａウィルス感染を処置する為のフェニル－ｎ－キノリン誘導体 |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US12084422B2 (enExample) |
| EP (2) | EP3594206A1 (enExample) |
| JP (2) | JP7504409B2 (enExample) |
| KR (1) | KR102758510B1 (enExample) |
| CN (1) | CN112566899B (enExample) |
| AU (1) | AU2019300100B2 (enExample) |
| BR (1) | BR112021000331A2 (enExample) |
| CU (1) | CU24674B1 (enExample) |
| MX (1) | MX2021000089A (enExample) |
| WO (1) | WO2020011810A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3594206A1 (en) * | 2018-07-09 | 2020-01-15 | Abivax | Phenyl-n-quinoline derivatives for treating a rna virus infection |
| EP3999493B1 (en) | 2019-07-19 | 2023-12-20 | Abivax | Aryl-n-aryl derivatives for treating a rna virus infection |
| BR112022018793A2 (pt) | 2020-03-20 | 2022-11-29 | Abivax | Uso de um composto de fórmula (i) ou (ii) para tratar ou previnir uma infecção por coronaviridae e condições relacionadas, composição farmacêutica e medicamento compreendendo os mesmos, uso de um mirna como um biomarcador de uma infecção por coronaviridae, e método para avaliar uma infecção por coronaviridae |
| EP3884946A1 (en) | 2020-03-25 | 2021-09-29 | Abivax | Compounds for treating or preventing a coronaviridae infection & methods and uses for assessing the occurrence of a coronaviridae infection |
| EP3881844A1 (en) | 2020-03-20 | 2021-09-22 | Abivax | Compounds for treating or preventing a coronaviridae infection & methods and uses for assessing the occurrence of a coronaviridae infection |
| IL326865A (en) * | 2023-08-30 | 2026-04-01 | Jiangsu Chia Tai Fenghai Pharmaceutical Co Ltd | Compound for regulating activity of microrna-124 |
| CN122514519A (zh) * | 2024-01-11 | 2026-08-04 | 豪夫迈·罗氏有限公司 | 杂芳基苯基醚衍生物 |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070244120A1 (en) | 2000-08-18 | 2007-10-18 | Jacques Dumas | Inhibition of raf kinase using substituted heterocyclic ureas |
| US7429599B2 (en) | 2000-12-06 | 2008-09-30 | Signal Pharmaceuticals, Llc | Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK |
| FR2830862A1 (fr) | 2001-10-16 | 2003-04-18 | Lipha | Derives nitroso de la diphenylamine a fonction ether ou thioether, compositions pharmaceutiques les contenant et leur utilisation pour la preparation de medicaments |
| FR2836917B1 (fr) | 2002-03-11 | 2006-02-24 | Lipha | Derives nitroso de la diphenylamine, compositions pharmaceutiques les contenant en tant que medicaments utilisables dans le traitement des pathologies caracterisees par une situation de stress oxydatif |
| AP2006003552A0 (en) | 2003-08-21 | 2006-04-30 | Osi Pharm Inc | N3 - substituted imidazopyridine C-kit inhibitors. |
| FR2859474B1 (fr) | 2003-09-04 | 2006-01-13 | Centre Nat Rech Scient | Utilisation de composes derives d'indole pour la preparation d'un medicament utile pour le traitement de maladies genetiques resultant de l'alteration des processus d'epissage |
| ATE435222T1 (de) | 2003-12-18 | 2009-07-15 | Tibotec Pharm Ltd | Aminobenzimidazole und benzimidazole als inhibitoren der replikation von respiratory syncytial virus |
| FR2866647B1 (fr) * | 2004-02-20 | 2006-10-27 | Servier Lab | Nouveaux derives azabicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| US20060069110A1 (en) | 2004-09-27 | 2006-03-30 | Andersen Denise L | Substituted heterocyclic compounds and methods of use |
| RU2410382C2 (ru) | 2005-03-17 | 2011-01-27 | Тиботек Фармасьютикалз Лтд | 1, 3-дигидробензимидазол-2-илиденовые амины в качестве ингибиторов репликации респираторного синцитиального вируса |
| US9409856B2 (en) | 2005-11-28 | 2016-08-09 | Gtx, Inc. | Estrogen receptor ligands and methods of use thereof |
| WO2007081517A2 (en) | 2005-12-21 | 2007-07-19 | Abbott Laboratories | Anti-viral compounds |
| WO2007076035A2 (en) | 2005-12-21 | 2007-07-05 | Abbott Laboratories | Anti-viral compounds |
| FR2901273B1 (fr) | 2006-05-19 | 2010-12-24 | Anaconda Pharma | Inhibiteurs du virus du papillome humain et les compositions pharmaceutiques les contenant |
| FR2926297B1 (fr) | 2008-01-10 | 2013-03-08 | Centre Nat Rech Scient | Molecules chimiques inhibitrices du mecanisme d'epissage pour traiter des maladies resultant d'anomalies d'epissage. |
| US20140187641A1 (en) | 2012-08-23 | 2014-07-03 | Gtx | Estrogen receptor ligands and methods of use thereof |
| CN102625804B (zh) | 2009-06-12 | 2015-04-08 | Abivax公司 | 用于治疗aids的化合物 |
| JP2011026251A (ja) | 2009-07-27 | 2011-02-10 | Kowa Co | ２−アリールアミノキノリン化合物及びこれを有効成分として含有するエリスロポエチン産生促進剤 |
| AU2011270994B2 (en) | 2010-06-24 | 2015-12-10 | Takeda Pharmaceutical Company Limited | Fused heterocyclic compounds as phosphodiesterases (PDES) inhibitors |
| EP2465502A1 (en) * | 2010-12-15 | 2012-06-20 | Société Splicos | Compounds useful for treating AIDS |
| EP2505198A1 (en) | 2011-04-01 | 2012-10-03 | Société Splicos | Compounds for use as therapeutic agents affecting p53 expression and/or activity |
| WO2014164667A1 (en) | 2013-03-11 | 2014-10-09 | Georgetown University | Dengue and west nile virus protease inhibitors |
| CA2916623C (en) * | 2013-07-05 | 2021-09-14 | Abivax | Bicyclic compounds useful for treating diseases caused by retroviruses |
| RU2628800C2 (ru) | 2014-03-12 | 2017-08-22 | Общество С Ограниченной Ответственностью "Фарминтерпрайсез" | Амидные соединения, способы получения, применение в качестве средств для лечения и профилактики заболеваний, вызываемых рнк-содержащими вирусами |
| WO2016086153A2 (en) | 2014-11-26 | 2016-06-02 | Esanex, Inc. | Use of tetrahydro!ndazolylbeimzamide and tetrahydroindolylbenzamide derivatives for the treatment of human immunodeficiency virus (hiv) and acquired immune deficiency syndrome (aids) |
| EP3059591A1 (en) * | 2015-02-23 | 2016-08-24 | Abivax | Methods for screening compounds for treating or preventing a viral infection or a virus-related condition |
| EP3058940A1 (en) * | 2015-02-23 | 2016-08-24 | Abivax | Quinoline derivatives for use in the treatment or prevention of viral infection |
| WO2017158201A1 (en) | 2016-03-18 | 2017-09-21 | Ratiopharm Gmbh | Process for preparing quinolin-2-yl-phenylamine derivatives and their salts |
| EP3594206A1 (en) * | 2018-07-09 | 2020-01-15 | Abivax | Phenyl-n-quinoline derivatives for treating a rna virus infection |
-
2018
- 2018-07-09 EP EP18305910.4A patent/EP3594206A1/en not_active Ceased
-
2019
- 2019-07-09 CN CN201980045917.4A patent/CN112566899B/zh active Active
- 2019-07-09 JP JP2021500215A patent/JP7504409B2/ja active Active
- 2019-07-09 BR BR112021000331-2A patent/BR112021000331A2/pt active Search and Examination
- 2019-07-09 EP EP19737536.3A patent/EP3820852A1/en active Pending
- 2019-07-09 WO PCT/EP2019/068459 patent/WO2020011810A1/en not_active Ceased
- 2019-07-09 KR KR1020217001298A patent/KR102758510B1/ko active Active
- 2019-07-09 CU CU2021000006A patent/CU24674B1/es unknown
- 2019-07-09 AU AU2019300100A patent/AU2019300100B2/en active Active
- 2019-07-09 MX MX2021000089A patent/MX2021000089A/es unknown
- 2019-07-09 US US17/259,364 patent/US12084422B2/en active Active
-
2023
- 2023-10-17 JP JP2023179000A patent/JP7673362B2/ja active Active
-
2024
- 2024-05-10 US US18/660,578 patent/US12479802B2/en active Active
-
2025
- 2025-10-15 US US19/359,300 patent/US20260035348A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021524480A5 (enExample) | ||
| JP2021524482A5 (enExample) | ||
| JP2021524487A5 (enExample) | ||
| JP2024050527A5 (enExample) | ||
| AR035979A1 (es) | Derivados de quinolina, procedimientos para su preparacion, composiciones farmaceuticas que los comprenden, y usos de dichos compuestos para la preparacion de medicament0s | |
| JP2021535104A5 (enExample) | ||
| RU2005114486A (ru) | Производные сульфониламиноуксусной кислоты и их применение в качестве антагонистов рецепторов орексина | |
| JP2018507877A5 (enExample) | ||
| JP2004509118A5 (enExample) | ||
| JP2014503574A5 (enExample) | ||
| EA031655B1 (ru) | Бензимидазол-2-амины в качестве ингибиторов midhi | |
| JP2019519587A5 (enExample) | ||
| JP2020063289A5 (enExample) | ||
| JP2019508496A5 (enExample) | ||
| JP2004509114A5 (enExample) | ||
| JP2015532295A5 (enExample) | ||
| JP2010522765A5 (enExample) | ||
| JP2002030084A5 (enExample) | ||
| CA2916623A1 (en) | Bicyclic compounds useful for treating diseases caused by retroviruses | |
| RU2004100302A (ru) | Амиды антраниловой кислоты с гетероарилсульфонильной боковой цепью, способ их получения, их применение в качестве лекарственного или диагностического средства, а также содержащие их фармацевтические композиции | |
| JP2019535723A5 (enExample) | ||
| JP2021500332A5 (enExample) | ||
| JP2019530674A5 (enExample) | ||
| JP2020525516A (ja) | 注射用組成物 | |
| JP2008508248A5 (enExample) |